• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Bajaj Healthcare Limited — Board Meeting, 17-10-2025: Outcome of Board Meeting

    17-10-2025 | 07:04 pm

    Bajaj Healthcare's board approved Q2 FY26 results: net profit from continuing operations reached ₹12.45 Cr. The company confirmed its ₹10.85 Cr Genrx Pharma acquisition, pending NCLT approval for integration. Remaining ₹52.71 Cr from warrants is expected soon.

    No comments yet. Be the first to comment!

    All announcements from Bajaj Healthcare Limited